Jagsonpal Pharma

57
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE048B01035
  • NSEID: JAGSNPHARM
  • BSEID: 507789
INR
228.00
0.25 (0.11%)
BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 50.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 6.89% vs 28.76% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 13.71% vs 121.40% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 7.31% vs 17.69% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -22.18% vs 146.45% in Mar 2025

Compare Profit and Loss Results of Jagsonpal Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
287.00
349.00
-62.00
-17.77%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
287.00
349.00
-62.00
-17.77%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-3.00
3.00
100.00%
Raw Materials Consumed
105.00
219.00
-114.00
-52.05%
Power & Fuel Cost
0.00
21.00
-21.00
-100.00%
Employee Cost
70.00
18.00
52.00
288.89%
Operating Expenses
0.00
12.00
-12.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
28.00
15.00
13.00
86.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
2.00
-1.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
229.00
292.00
-63.00
-21.58%
Operating Profit (PBDIT) excl Other Income
58.00
56.00
2.00
3.57%
Other Income
11.00
6.00
5.00
83.33%
Operating Profit (PBDIT)
70.00
63.00
7.00
11.11%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
69.00
62.00
7.00
11.29%
Depreciation
9.00
4.00
5.00
125.00%
Profit Before Taxation & Exceptional Items
59.00
58.00
1.00
1.72%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
57.00
58.00
-1.00
-1.72%
Provision for Tax
14.00
14.00
0.00
0.00%
Profit After Tax
43.00
43.00
0.00
0.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
148.00
96.00
52.00
54.17%
Profit Available for appropriations
191.00
140.00
51.00
36.43%
Appropriations
191.00
140.00
51.00
36.43%
Equity Dividend (%)
200%
10%
190.00
Earnings Per Share
6.4
18.65
-12.25
-65.68%
Profit And Loss - Net Sales
Net Sales 287.23 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 6.89% vs 28.76% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 58.07 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 13.71% vs 121.40% in Mar 2025

Profit And Loss - Interest
Interest 1.03 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 7.31% vs 17.69% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 43.08 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -22.18% vs 146.45% in Mar 2025